Pathways of antigen processing.

T cell recognition of antigen-presenting cells depends on their expression of a spectrum of peptides bound to major histocompatibility complex class I (MHC-I) and class II (MHC-II) molecules. Conversion of antigens from pathogens or transformed cells into MHC-I- and MHC-II-bound peptides is critical for mounting protective T cell responses, and similar processing of self proteins is necessary to establish and maintain tolerance. Cells use a variety of mechanisms to acquire protein antigens, from translation in the cytosol to variations on the theme of endocytosis, and to degrade them once acquired. In this review, we highlight the aspects of MHC-I and MHC-II biosynthesis and assembly that have evolved to intersect these pathways and sample the peptides that are produced.

[1]  P. Cresswell,et al.  HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides , 1992, Nature.

[2]  M. Brenner,et al.  Antigen Presentation by CD1 Lipids, T Cells, and NKT Cells in Microbial Immunity. , 2009, Advances in immunology.

[3]  T. Gao,et al.  Novel functions of murine B1 cells: Active phagocytic and microbicidal abilities , 2012, European journal of immunology.

[4]  J. Cazareth,et al.  Direct Visualization of Peptide/MHC Complexes at the Surface and in the Intracellular Compartments of Cells Infected In Vivo by Leishmania major , 2010, PLoS pathogens.

[5]  Akira Hattori,et al.  An IFN-γ–induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I–presented peptides , 2002, Nature Immunology.

[6]  C. Harding,et al.  Early endosomes and a late endocytic compartment generate different peptide-class II MHC complexes via distinct processing mechanisms. , 1997, Journal of immunology.

[7]  E. Pamer,et al.  Listeriolysin is processed efficiently into an MHC class I-associated epitope in Listeria monocytogenes-infected cells. , 1995, Journal of immunology.

[8]  P. Cresswell,et al.  Regulation of intracellular trafficking of human CD1d by association with MHC class II molecules , 2002, The EMBO journal.

[9]  Anna M. Keller,et al.  Efficient and versatile manipulation of the peripheral CD4+ T-cell compartment by antigen targeting to DNGR-1/CLEC9A , 2010, European journal of immunology.

[10]  S. Ceman,et al.  The function of invariant chain in class II-restricted antigen presentation. , 1995, Seminars in immunology.

[11]  R. Das,et al.  A Family of IFN-γ–Inducible 65-kD GTPases Protects Against Bacterial Infection , 2011, Science.

[12]  G. Hämmerling,et al.  Editing of the HLA‐DR‐peptide repertoire by HLA‐DM. , 1996, The EMBO journal.

[13]  Wei Jiang,et al.  HLA-DO acts as a substrate mimic to inhibit HLA-DM by a competitive mechanism , 2012, Nature Structural &Molecular Biology.

[14]  D. Green,et al.  Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis , 2007, Nature.

[15]  C. Watts,et al.  Cycling of cell-surface MHC glycoproteins through primaquine-sensitive intracellular compartments , 1990, Nature.

[16]  D. Schadendorf,et al.  The Efficiency of Human Cytomegalovirus pp65495–503 CD8+ T Cell Epitope Generation Is Determined by the Balanced Activities of Cytosolic and Endoplasmic Reticulum-Resident Peptidases , 2012, The Journal of Immunology.

[17]  Maria L. Wei,et al.  HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides , 1992, Nature.

[18]  M. Sugita,et al.  Association of the Invariant Chain with Major Histocompatibility Complex Class I Molecules Directs Trafficking to Endocytic Compartments (*) , 1995, The Journal of Biological Chemistry.

[19]  P. Jensen,et al.  The expression of HLA-DO (H2-O) in B lymphocytes , 2004, Immunologic research.

[20]  Peter Cresswell,et al.  Hsp90-mediated cytosolic refolding of exogenous proteins internalized by dendritic cells , 2007, The EMBO journal.

[21]  J. Harding,et al.  Human Dendritic Cell Expression of HLA-DO Is Subset Specific and Regulated by Maturation1 , 2006, The Journal of Immunology.

[22]  J. Shabanowitz,et al.  An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins , 1996, The Journal of experimental medicine.

[23]  P. A. Peterson,et al.  Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways , 1990, Nature.

[24]  B. Fox,et al.  Tumor-Derived Autophagosome Vaccine: Mechanism of Cross-Presentation and Therapeutic Efficacy , 2011, Clinical Cancer Research.

[25]  A. Prescott,et al.  Enhanced Dendritic Cell Antigen Capture via Toll-Like Receptor-Induced Actin Remodeling , 2004, Science.

[26]  A. Rudensky,et al.  Efficient Presentation of Both Cytosolic and Endogenous Transmembrane Protein Antigens on MHC Class II Is Dependent on Cytoplasmic Proteolysis1 , 2001, The Journal of Immunology.

[27]  Susan Kovats,et al.  Presentation of abundant endogenous class II DR‐restricted antigens by DM‐negative B cell lines , 1997, European journal of immunology.

[28]  A. Hermetter,et al.  Macrophage Activation Downregulates the Degradative Capacity of the Phagosome , 2007, Traffic.

[29]  P. Cresswell,et al.  Defective Cross-Presentation of Viral Antigens in GILT-Free Mice , 2010, Science.

[30]  M. Molinari,et al.  The glycan code of the endoplasmic reticulum: asparagine-linked carbohydrates as protein maturation and quality-control tags. , 2005, Trends in cell biology.

[31]  P. Cresswell,et al.  Absence of γ-Interferon–inducible Lysosomal Thiol Reductase in Melanomas Disrupts T Cell Recognition of Select Immunodominant Epitopes , 2002, The Journal of experimental medicine.

[32]  R. Tampé,et al.  A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. , 1997, Science.

[33]  J. Calafat,et al.  Regulation of MHC Class II Antigen Presentation by Sorting of Recycling HLA-DM/DO and Class II within the Multivesicular Body1 , 2001, The Journal of Immunology.

[34]  Nadia Catalan,et al.  MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation , 2008, Proceedings of the National Academy of Sciences.

[35]  L. Kaer,et al.  Impaired assembly yet normal trafficking of MHC class I molecules in Tapasin mutant mice. , 2000, Immunity.

[36]  A. Iwasaki,et al.  Adaptor protein-3 in dendritic cells facilitates phagosomal toll-like receptor signaling and antigen presentation to CD4(+) T cells. , 2012, Immunity.

[37]  S. H. van der Burg,et al.  CD8+ T Cell Responses against TAP-Inhibited Cells Are Readily Detected in the Human Population , 2010, The Journal of Immunology.

[38]  I. Mellman,et al.  Invariant Chain Controls H2-M Proteolysis in Mouse Splenocytes and Dendritic Cells , 2000, The Journal of experimental medicine.

[39]  P. Cresswell,et al.  GILT Accelerates Autoimmunity to the Melanoma Antigen Tyrosinase-Related Protein 1 , 2010, The Journal of Immunology.

[40]  J. Harding,et al.  Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression , 2005, Immunological reviews.

[41]  H. Davidson,et al.  Endocytosis, intracellular trafficking, and processing of membrane IgG and monovalent antigen/membrane IgG complexes in B lymphocytes. , 1990, Journal of immunology.

[42]  W. Jefferies,et al.  Comparison of cell lines deficient in antigen presentation reveals a functional role for TAP-1 alone in antigen processing , 1994, The Journal of experimental medicine.

[43]  Jonathan W. Yewdell,et al.  Rapid degradation of a large fraction of newly synthesized proteins by proteasomes , 2000, Nature.

[44]  Anna M. Keller,et al.  Identification of a dendritic cell receptor that couples sensing of necrosis to immunity , 2009, Nature.

[45]  L. Denzin,et al.  Ectopic Expression of HLA-DO in Mouse Dendritic Cells Diminishes MHC Class II Antigen Presentation1 , 2004, The Journal of Immunology.

[46]  C. Watts,et al.  The endosome–lysosome pathway and information generation in the immune system☆ , 2012, Biochimica et biophysica acta.

[47]  P. A. Peterson,et al.  Altered antigen presentation in mice lacking H2-O. , 1998, Immunity.

[48]  P. Cresswell,et al.  A role for the endoplasmic reticulum protein retrotranslocation machinery during crosspresentation by dendritic cells. , 2006, Immunity.

[49]  R. Xavier,et al.  Autophagy and the immune system. , 2012, Annual review of immunology.

[50]  J. Bonifacino,et al.  A lysosomal targeting signal in the cytoplasmic tail of the beta chain directs HLA-DM to MHC class II compartments , 1995, The Journal of cell biology.

[51]  J. Strominger,et al.  Trafficking of spontaneously endocytosed MHC proteins. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[52]  J. Blum,et al.  HSP90α and HSP90β Isoforms Selectively Modulate MHC Class II Antigen Presentation in B Cells1 , 2009, The Journal of Immunology.

[53]  M. Knittler,et al.  Critical Role for the Tapasin-Docking Site of TAP2 in the Functional Integrity of the MHC Class I-Peptide-Loading Complex1 , 2005, The Journal of Immunology.

[54]  Kaan E. Biron,et al.  Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain , 2003, Nature Immunology.

[55]  P. Cresswell,et al.  HLA-DM induces clip dissociation from MHC class II αβ dimers and facilitates peptide loading , 1995, Cell.

[56]  K. Rock,et al.  Analysis of MHC class II presentation of particulate antigens of B lymphocytes. , 1996, Journal of immunology.

[57]  E. Unanue,et al.  T cells distinguish MHC-peptide complexes formed in separate vesicles and edited by H2-DM. , 2004, Immunity.

[58]  K. Kitajima,et al.  Purification and enzymatic properties of peptide:N-glycanase from C3H mouse-derived L-929 fibroblast cells. Possible widespread occurrence of post-translational remodification of proteins by N-deglycosylation. , 1994, The Journal of biological chemistry.

[59]  R. Hunter,et al.  Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells , 2009, Nature Medicine.

[60]  B. J. Van den Eynde,et al.  Insights into the processing of MHC class I ligands gained from the study of human tumor epitopes , 2011, Cellular and Molecular Life Sciences.

[61]  Richard A. Flavell,et al.  Defective Antigen Processing in GILT-Free Mice , 2001, Science.

[62]  A. Goldberg,et al.  Interferon-γ Can Stimulate Post-proteasomal Trimming of the N Terminus of an Antigenic Peptide by Inducing Leucine Aminopeptidase* , 1998, The Journal of Biological Chemistry.

[63]  Shu-Bing Qian,et al.  Quantitating protein synthesis, degradation, and endogenous antigen processing. , 2003, Immunity.

[64]  M. Boes,et al.  Recruitment of Rab27a to Phagosomes Controls Microbial Antigen Cross-Presentation by Dendritic Cells , 2008, Infection and Immunity.

[65]  C. Benoist,et al.  Mice Lacking H2-M Complexes, Enigmatic Elements of the MHC Class II Peptide-Loading Pathway , 1996, Cell.

[66]  Jeffrey K. Mito,et al.  An Antigen Produced by Splicing of Noncontiguous Peptides in the Reverse Order , 2006, Science.

[67]  E. Adams,et al.  The adaptable major histocompatibility complex (MHC) fold: structure and function of nonclassical and MHC class I-like molecules. , 2013, Annual review of immunology.

[68]  J. Weissman,et al.  Road to Ruin: Targeting Proteins for Degradation in the Endoplasmic Reticulum , 2011, Science.

[69]  M. Brenner,et al.  Chapter 1 Antigen Presentation by CD1 , 2009 .

[70]  Thierry Boon,et al.  Human T cell responses against melanoma. , 2006, Annual review of immunology.

[71]  R. Inman,et al.  Immunodominance: a pivotal principle in host response to viral infections. , 2012, Clinical immunology.

[72]  P. Cresswell,et al.  The redox activity of ERp57 is not essential for its functions in MHC class I peptide loading , 2008, Proceedings of the National Academy of Sciences.

[73]  T. Elliott,et al.  Tapasin enhances MHC class I peptide presentation according to peptide half-life. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[74]  F. Graham,et al.  Identification of an immunodominant cytotoxic T-lymphocyte recognition site in glycoprotein B of herpes simplex virus by using recombinant adenovirus vectors and synthetic peptides , 1991, Journal of virology.

[75]  P. Cresswell,et al.  Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding , 1990, Nature.

[76]  D. Wiley,et al.  Identification of domain boundaries within the N‐termini of TAP1 and TAP2 and their importance in tapasin binding and tapasin‐mediated increase in peptide loading of MHC class I , 2005, Immunology and cell biology.

[77]  J. Enninga,et al.  Sec22b Regulates Phagosomal Maturation and Antigen Crosspresentation by Dendritic Cells , 2011, Cell.

[78]  H. Ploegh,et al.  Control of cross‐presentation during dendritic cell maturation , 2004, European journal of immunology.

[79]  J. Blum,et al.  Receptor-mediated endocytosis of antigens overcomes the requirement for HLA-DM in class II-restricted antigen presentation. , 1997, Journal of immunology.

[80]  P. Allen,et al.  Constitutive competition by self proteins for antigen presentation can be overcome by receptor-enhanced uptake. , 1990, Journal of immunology.

[81]  R. Fåhraeus,et al.  Major source of antigenic peptides for the MHC class I pathway is produced during the pioneer round of mRNA translation , 2011, Proceedings of the National Academy of Sciences.

[82]  C. Harding,et al.  MHC molecules and microbial antigen processing in phagosomes. , 2009, Current opinion in immunology.

[83]  H. Geuze,et al.  Class II MHC molecules are present in macrophage lysosomes and phagolysosomes that function in the phagocytic processing of Listeria monocytogenes for presentation to T cells , 1992, The Journal of cell biology.

[84]  D. Zaller,et al.  Mediation by HLA-DM of dissociation of peptides from HLA-DR , 1995, Nature.

[85]  S. Ceman,et al.  Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. , 1992, Science.

[86]  Eric O Long,et al.  Cell surface HLA-DR-invariant chain complexes are targeted to endosomes by rapid internalization. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[87]  Sarah Siddiqui,et al.  CD8+ T Cell Immunodominance in Lymphocytic Choriomeningitis Virus Infection Is Modified in the Presence of Toll-Like Receptor Agonists , 2011, Journal of Virology.

[88]  P. Roche,et al.  Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation , 2000, Nature Immunology.

[89]  Sven Burgdorf,et al.  Distinct Pathways of Antigen Uptake and Intracellular Routing in CD4 and CD8 T Cell Activation , 2007, Science.

[90]  P. Cresswell,et al.  Co-localization of molecules involved in antigen processing and presentation in an early endocytic compartment , 1990, Nature.

[91]  M. van Lith,et al.  HLA-DP, HLA-DQ, and HLA-DR Have Different Requirements for Invariant Chain and HLA-DM* , 2010, The Journal of Biological Chemistry.

[92]  A. Heine,et al.  Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro-transcribed MUC1 RNA. , 2005, Blood.

[93]  J. McCluskey,et al.  Distinct Functions of Tapasin Revealed by Polymorphism in MHC Class I Peptide Loading1 , 2000, The Journal of Immunology.

[94]  A. Goldberg,et al.  26S proteasomes and immunoproteasomes produce mainly N‐extended versions of an antigenic peptide , 2001, The EMBO journal.

[95]  E. Unanue,et al.  Register shifting of an insulin peptide–MHC complex allows diabetogenic T cells to escape thymic deletion , 2011, The Journal of experimental medicine.

[96]  J. Isaacs,et al.  Inhibition of macropinocytosis blocks antigen presentation of type II collagen in vitro and in vivo in HLA-DR1 transgenic mice , 2006, Arthritis research & therapy.

[97]  V. Crotzer,et al.  Autophagy and adaptive immunity , 2010, Immunology.

[98]  R. Steinman,et al.  In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell Vaccination , 2004, The Journal of experimental medicine.

[99]  J. Sibarita,et al.  Jcb: Article , 2022 .

[100]  Rachelle Gaudet,et al.  Structure of the ABC ATPase domain of human TAP1, the transporter associated with antigen processing , 2001, The EMBO journal.

[101]  K. Wucherpfennig,et al.  Targeted regulation of self-peptide presentation prevents type I diabetes in mice without disrupting general immunocompetence. , 2010, The Journal of clinical investigation.

[102]  C. Hunter,et al.  Pivotal Advance: Peritoneal cavity B‐1 B cells have phagocytic and microbicidal capacities and present phagocytosed antigen to CD4+ T cells , 2012, Journal of leukocyte biology.

[103]  P. Cresswell,et al.  Invariant chain trimers are sequestered in the rough endoplasmic reticulum in the absence of association with HLA class II antigens , 1990, The Journal of cell biology.

[104]  I. Nishino,et al.  LAMP‐2‐deficient human B cells exhibit altered MHC class II presentation of exogenous antigens , 2010, Immunology.

[105]  R. Kaufman,et al.  Substrate-specific requirements for UGT1-dependent release from calnexin. , 2007, Molecular cell.

[106]  Mark S. Anderson,et al.  The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44 , 1993, Cell.

[107]  Mario Schelhaas Come in and take your coat off – how host cells provide endocytosis for virus entry , 2010, Cellular microbiology.

[108]  S. Ishido,et al.  E3 ubiquitin ligases for MHC molecules. , 2009, Current opinion in immunology.

[109]  D. Weber,et al.  DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. , 1995, Immunity.

[110]  A. Helenius,et al.  Minor folding defects trigger local modification of glycoproteins by the ER folding sensor GT , 2005, The EMBO journal.

[111]  R. Germain,et al.  Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expression , 1993, The Journal of experimental medicine.

[112]  N. Nagarajan,et al.  Endoplasmic Reticulum Aminopeptidase Associated with Antigen Processing Defines the Composition and Structure of MHC Class I Peptide Repertoire in Normal and Virus-Infected Cells , 2010, The Journal of Immunology.

[113]  A. Goldberg,et al.  Structural Basis For Antigenic Peptide Precursor Processing by the Endoplasmic Reticulum Aminopeptidase ERAP1 , 2011, Nature Structural &Molecular Biology.

[114]  R. Germain,et al.  Related Leucine-based Cytoplasmic Targeting Signals in Invariant Chain and Major Histocompatibility Complex Class II Molecules Control Endocytic Presentation of Distinct Determinants in a Single Protein , 1997, The Journal of experimental medicine.

[115]  J. Neefjes,et al.  Translocation of long peptides by transporters associated with antigen processing (TAP) , 1996, European journal of immunology.

[116]  P. Taylor,et al.  Altered major histocompatibility complex class II peptide loading in H2‐O‐deficient mice , 2000, European journal of immunology.

[117]  D. Russell,et al.  Phagosome maturation proceeds independently of stimulation of toll-like receptors 2 and 4. , 2005, Immunity.

[118]  O. Mandelboim,et al.  Recruitment of MHC Class I Molecules by Tapasin into the Transporter Associated with Antigen Processing-Associated Complex Is Essential for Optimal Peptide Loading , 2002, The Journal of Immunology.

[119]  S. Mukherjee,et al.  Subversion of membrane transport pathways by vacuolar pathogens , 2011, The Journal of cell biology.

[120]  N. Shastri,et al.  Leucine-tRNA Initiates at CUG Start Codons for Protein Synthesis and Presentation by MHC Class I , 2012, Science.

[121]  T. Braciale,et al.  Presentation of viral antigen to class I major histocompatibility complex-restricted cytotoxic T lymphocyte. Recognition of an immunodominant influenza hemagglutinin site by cytotoxic T lymphocyte is independent of the position of the site in the hemagglutinin translation product , 1991, The Journal of experimental medicine.

[122]  R. Tampé,et al.  Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[123]  P. Kearney,et al.  Modulation of the Phagosome Proteome by Interferon-γ*S , 2008, Molecular & Cellular Proteomics.

[124]  N. Shastri,et al.  The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules , 2006, Nature Immunology.

[125]  P. Srivastava,et al.  High efficiency CD91- and LOX-1-mediated re-presentation of gp96-chaperoned peptides by MHC II molecules. , 2010, Cancer Immunity.

[126]  William Arbuthnot Sir Lane,et al.  Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles , 1993, The Journal of experimental medicine.

[127]  C. Münz Antigen Processing for MHC Class II Presentation via Autophagy , 2012, Front. Immun..

[128]  M. Anderson,et al.  Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[129]  P. Gleeson,et al.  Macropinocytosis: an endocytic pathway for internalising large gulps , 2011, Immunology and cell biology.

[130]  K. Orth,et al.  Manipulation of host membranes by bacterial effectors , 2011, Nature Reviews Microbiology.

[131]  N. Shastri,et al.  Hsp90alpha chaperones large C-terminally extended proteolytic intermediates in the MHC class I antigen processing pathway. , 2006, Immunity.

[132]  D. Zaller,et al.  The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation. , 1998, Immunity.

[133]  Ari Helenius,et al.  Endosome maturation , 2011, The EMBO journal.

[134]  T. Elliott,et al.  Assembly and antigen-presenting function of MHC class I molecules in cells lacking the ER chaperone calreticulin. , 2002, Immunity.

[135]  Sébastien Lemieux,et al.  MHC I-associated peptides preferentially derive from transcripts bearing miRNA response elements. , 2012, Blood.

[136]  L. Denzin,et al.  Expression Patterns of H2-O in Mouse B Cells and Dendritic Cells Correlate with Cell Function1 , 2007, The Journal of Immunology.

[137]  P. Cresswell,et al.  A Switch in Pathogenic Mechanism in Myelin Oligodendrocyte Glycoprotein-Induced Experimental Autoimmune Encephalomyelitis in IFN-γ–Inducible Lysosomal Thiol Reductase-Free Mice , 2012, Journal of Immunology.

[138]  E. Sercarz,et al.  MHC-guided processing: binding of large antigen fragments , 2003, Nature Reviews Immunology.

[139]  J. Yewdell,et al.  DRiPs solidify: progress in understanding endogenous MHC class I antigen processing. , 2011, Trends in immunology.

[140]  C. Watts The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules , 2004, Nature Immunology.

[141]  Partho Ghosh,et al.  The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3 , 1995, Nature.

[142]  H. Geuze,et al.  The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route , 1990, Cell.

[143]  R. Mehr,et al.  CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain. , 2001, Immunity.

[144]  A. Lanzavecchia,et al.  Processed antigen binds to newly synthesized mhc class II molecules in antigen-specific B lymphocytes , 1991, Cell.

[145]  E. Williamson,et al.  The Actin Regulatory Protein HS1 Is Required for Antigen Uptake and Presentation by Dendritic Cells , 2011, The Journal of Immunology.

[146]  H. Eisen,et al.  Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. , 1996, Immunity.

[147]  A. Knight,et al.  Lowering the affinity between antigen and the B cell receptor can enhance antigen presentation , 2004, European journal of immunology.

[148]  Doktorgrades Der Naturwissenschaften,et al.  Autophagy in Thymic Epithelium Shapes the T cell Repertoire and is Essential for Tolerance , 2009 .

[149]  E. Unanue,et al.  Low‐temperature inhibition of antigen processing and iron uptake from transferrin: Deficits in endosome functions at 18 °C , 1990 .

[150]  L. Santambrogio,et al.  Microautophagy of cytosolic proteins by late endosomes. , 2011, Developmental cell.

[151]  P. Cresswell,et al.  Disulfide bond isomerization and the assembly of MHC class I-peptide complexes. , 2002, Immunity.

[152]  Antonio Lanzavecchia,et al.  Antigen-specific interaction between T and B cells , 1985, Nature.

[153]  P. Zhang,et al.  Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk , 2011, Nature Immunology.

[154]  Li Wu,et al.  Selective suicide of cross-presenting CD8+ dendritic cells by cytochrome c injection shows functional heterogeneity within this subset , 2008, Proceedings of the National Academy of Sciences.

[155]  C. Watts,et al.  Capture and processing of exogenous antigens for presentation on MHC molecules. , 1997, Annual review of immunology.

[156]  P. Cresswell,et al.  Negative regulation by HLA-DO of MHC class II-restricted antigen processing. , 1997, Science.

[157]  R. Tampé,et al.  Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation , 2008, Nature Immunology.

[158]  A. Prescott,et al.  The coated pit and macropinocytic pathways serve distinct endosome populations , 1994, The Journal of cell biology.

[159]  R. Tampé,et al.  Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells , 2005, Nature Immunology.

[160]  J. Maupin-Furlow Proteasomes and protein conjugation across domains of life , 2011, Nature Reviews Microbiology.

[161]  M. Bouvier,et al.  Analysis of interactions in a tapasin/class I complex provides a mechanism for peptide selection , 2007, The EMBO journal.

[162]  Don C. Wiley,et al.  Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide , 1994, Nature.

[163]  S. Amigorena,et al.  Intracellular mechanisms of antigen cross presentation in dendritic cells. , 2010, Current opinion in immunology.

[164]  D. Wiley,et al.  The antigenic identity of peptide-MHC complexes: A comparison of the conformations of five viral peptides presented by HLA-A2 , 1993, Cell.

[165]  G. Raposo,et al.  NOX2 Controls Phagosomal pH to Regulate Antigen Processing during Crosspresentation by Dendritic Cells , 2006, Cell.

[166]  L. Schomburg,et al.  Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum , 2005, Nature Immunology.

[167]  N. Shastri,et al.  In the absence of aminopeptidase ERAAP, MHC class I molecules present many unstable and highly immunogenic peptides , 2007, Nature Immunology.

[168]  Subrat N. Rout,et al.  The MHC Class II-Associated Invariant Chain Interacts with the Neonatal Fcγ Receptor and Modulates Its Trafficking to Endosomal/Lysosomal Compartments1 , 2008, The Journal of Immunology.

[169]  P. Cresswell,et al.  Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin-ERp57 heterodimer , 2007, Nature Immunology.

[170]  A. Diehl,et al.  Impaired immune responses and altered peptide repertoire in tapasin-deficient mice , 2000, Nature Immunology.

[171]  C. Harding,et al.  Mycobacterium tuberculosis Heat Shock Fusion Protein Enhances Class I MHC Cross-Processing and -Presentation by B Lymphocytes1 , 2005, The Journal of Immunology.

[172]  T. Tree,et al.  Reconstruction of a pathway of antigen processing and class II MHC peptide capture , 2007, The EMBO journal.

[173]  Jun Kunisawa,et al.  The group II chaperonin TRiC protects proteolytic intermediates from degradation in the MHC class I antigen processing pathway. , 2003, Molecular cell.

[174]  T. Elliott,et al.  Proteasomes, TAP, and Endoplasmic Reticulum-Associated Aminopeptidase Associated with Antigen Processing Control CD4+ Th Cell Responses by Regulating Indirect Presentation of MHC Class II-Restricted Cytoplasmic Antigens , 2011, The Journal of Immunology.

[175]  A. Rudensky,et al.  Invariant Chain–independent Function of H-2M in the Formation of Endogenous Peptide–Major Histocompatibility Complex Class II Complexes In Vivo , 1998, The Journal of experimental medicine.

[176]  P. A. Peterson,et al.  The MHC class II molecule H2-M is targeted to an endosomal compartment by a tyrosine-based targeting motif. , 1995, Immunity.

[177]  H. Ploegh,et al.  Upregulation of the CLIP self peptide on mature dendritic cells antagonizes T helper type 1 polarization , 2004, Nature Immunology.

[178]  P. Cresswell,et al.  Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. , 1996, Immunity.

[179]  F. Momburg,et al.  Impaired assembly of the major histocompatibility complex class I peptide-loading complex in mice deficient in the oxidoreductase ERp57 , 2006, Nature Immunology.

[180]  J. Blum,et al.  Endocytic Recycling is Required for the Presentation of an Exogenous Peptide via MHC Class II Molecules , 2000, Traffic.

[181]  J. Davey,et al.  Cytotoxic T cells recognize fragments of the influenza nucleoprotein , 1985, Cell.

[182]  P. Zhang,et al.  Constitutive MHC class I molecules negatively regulate TLR-triggered inflammatory responses via the Fps–SHP-2 pathway , 2012, Journal of Translational Medicine.

[183]  Etienne Gagnon,et al.  Phagosomes are competent organelles for antigen cross-presentation , 2003, Nature.

[184]  Yuriko Tanaka,et al.  Liposome-Coupled Antigens Are Internalized by Antigen-Presenting Cells via Pinocytosis and Cross-Presented to CD8+ T Cells , 2010, PloS one.

[185]  W. Jefferies,et al.  A CD74-DEPENDENT MHC CLASS I ENDOLYSOSOMAL CROSS-PRESENTATION PATHWAY , 2012, Nature Immunology.

[186]  R. Dwek,et al.  Folding of an MHC class II-restricted tumor antigen controls its antigenicity via MHC-guided processing , 2007, Proceedings of the National Academy of Sciences.

[187]  G. de Prat-Gay,et al.  The Endoplasmic Reticulum Glucosyltransferase Recognizes Nearly Native Glycoprotein Folding Intermediates* , 2004, Journal of Biological Chemistry.

[188]  P. Cresswell,et al.  A role for UDP-glucose glycoprotein glucosyltransferase in expression and quality control of MHC class I molecules , 2011, Proceedings of the National Academy of Sciences.

[189]  Etienne Gagnon,et al.  Endoplasmic Reticulum-Mediated Phagocytosis Is a Mechanism of Entry into Macrophages , 2002, Cell.

[190]  C. Reis e Sousa,et al.  Cross‐presentation of cell‐associated antigens by CD8α+ dendritic cells is attributable to their ability to internalize dead cells , 2002, Immunology.

[191]  K. Sakaguchi,et al.  The proteolytic environment involved in MHC class II-restricted antigen presentation can be modulated by the p41 form of invariant chain. , 1996, Journal of immunology.

[192]  E. Unanue,et al.  In Autoimmune Diabetes Unique Autoreactive T Cells Recognize Insulin Peptides Generated in the Islets of Langerhans , 2010, Nature Immunology.

[193]  R. Tampé,et al.  ABC transporters and immunity: mechanism of self-defense. , 2012, Biochemistry.

[194]  C. Melief,et al.  Dendritic cells regulate exposure of MHC class II at their plasma membrane by oligoubiquitination. , 2006, Immunity.

[195]  H. Geuze,et al.  Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments , 1991, Nature.

[196]  Karin M Reinisch,et al.  Insights into MHC class I peptide loading from the structure of the tapasin-ERp57 thiol oxidoreductase heterodimer. , 2009, Immunity.

[197]  Wei Jiang,et al.  Mapping the HLA-DO/HLA-DM complex by FRET and mutagenesis , 2012, Proceedings of the National Academy of Sciences.

[198]  J. Neefjes,et al.  The major substrates for TAP in vivo are derived from newly synthesized proteins , 2000, Nature.

[199]  L. Eisenlohr,et al.  A cytosolic pathway for MHC class II–restricted antigen processing that is proteasome and TAP dependent , 2005, Nature Immunology.

[200]  O. Bakke,et al.  MHC II and the Endocytic Pathway: Regulation by Invariant Chain , 2009, Scandinavian journal of immunology.

[201]  P. Cresswell,et al.  Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain , 1991, Nature.

[202]  T. Reinheckel,et al.  Specific functions of lysosomal proteases in endocytic and autophagic pathways☆ , 2011, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics.

[203]  T. Boon,et al.  An Antigenic Peptide Produced by Peptide Splicing in the Proteasome , 2004, Science.

[204]  P. Cresswell,et al.  Dynamics of Major Histocompatibility Complex Class I Association with the Human Peptide-loading Complex , 2012, The Journal of Biological Chemistry.

[205]  R. Tampé,et al.  Functional Dissection of the Transmembrane Domains of the Transporter Associated with Antigen Processing (TAP)* , 2004, Journal of Biological Chemistry.

[206]  Gavin W. Porter,et al.  TLR Agonists Downregulate H2-O in CD8α− Dendritic Cells , 2011, The Journal of Immunology.

[207]  E. Unanue,et al.  Functional and ultrastructural evidence for intracellular formation of major histocompatibility complex class II-peptide complexes during antigen processing. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[208]  D. Fremont,et al.  Crystal structure of mouse H2-M. , 1998, Immunity.

[209]  A. Rickinson,et al.  T Cell Detection of a B-Cell Tropic Virus Infection: Newly-Synthesised versus Mature Viral Proteins as Antigen Sources for CD4 and CD8 Epitope Display , 2009, PLoS pathogens.

[210]  I. Mellman,et al.  Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis , 2006, The Journal of experimental medicine.

[211]  H. Ruley,et al.  H2-M Mutant Mice Are Defective in the Peptide Loading of Class II Molecules, Antigen Presentation, and T Cell Repertoire Selection , 1996, Cell.

[212]  R. Cole,et al.  A reductionist cell-free major histocompatibility complex class II antigen processing system identifies immunodominant epitopes , 2010, Nature Medicine.

[213]  M. Molinari,et al.  N-glycan processing in ER quality control , 2006, Journal of Cell Science.

[214]  E. Sercarz,et al.  N‐terminal flanking residues of a diabetes‐associated GAD65 determinant are necessary for activation of antigen‐specific T cells in diabetes‐resistant mice , 2008, European journal of immunology.

[215]  M. Garcia-Peydró,et al.  Quantitative and Qualitative Influences of Tapasin on the Class I Peptide Repertoire1 , 2001, The Journal of Immunology.

[216]  Henry C. Chang,et al.  Differential Lysosomal Proteolysis in Antigen-Presenting Cells Determines Antigen Fate , 2005, Science.

[217]  P. A. Peterson,et al.  Antigen Presentation and T Cell Development in H2-M-Deficient Mice , 1996, Science.

[218]  R. Hunter,et al.  Processing and Presentation of a Mycobacterial Antigen 85B Epitope by Murine Macrophages Is Dependent on the Phagosomal Acquisition of Vacuolar Proton ATPase and In Situ Activation of Cathepsin D1 , 2006, The Journal of Immunology.

[219]  N. Shastri,et al.  ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum , 2002, Nature.

[220]  A. Sant,et al.  Dm Determines the Cryptic and Immunodominant Fate of T Cell Epitopes , 2000, The Journal of experimental medicine.

[221]  M. Jackson,et al.  HLA‐DO is a lysosomal resident which requires association with HLA‐DM for efficient intracellular transport. , 1996, The EMBO journal.

[222]  M. Jackson,et al.  A Role for Acidic Residues in Di-leucine Motif-based Targeting to the Endocytic Pathway (*) , 1995, The Journal of Biological Chemistry.

[223]  P. Cresswell,et al.  Essential glycan-dependent interactions optimize MHC class I peptide loading , 2011, Proceedings of the National Academy of Sciences.

[224]  James McCluskey,et al.  Optimization of the MHC class I peptide cargo is dependent on tapasin. , 2002, Immunity.

[225]  P. van Endert,et al.  IRAP Identifies an Endosomal Compartment Required for MHC Class I Cross-Presentation , 2009, Science.

[226]  R. Fåhraeus,et al.  The role of mRNA translation in direct MHC class I antigen presentation. , 2012, Current opinion in immunology.

[227]  J. Elliott,et al.  Cytoplasmic Processing Is a Prerequisite for Presentation of an Endogenous Antigen by Major Histocompatibility Complex Class II Proteins , 2000, The Journal of experimental medicine.

[228]  J. Blander Phagocytosis and antigen presentation: a partnership initiated by Toll-like receptors , 2008, Annals of the rheumatic diseases.

[229]  Jeffrey A. Shaman,et al.  An essential role for HLA–DM in antigen presentation by class II major histocompatibility molecules , 1994, Nature.

[230]  R. Tampé,et al.  Structural arrangement of the transmission interface in the antigen ABC transport complex TAP , 2009, Proceedings of the National Academy of Sciences.

[231]  J. Rothman,et al.  Receptor-Mediated Uptake of Antigen/Heat Shock Protein Complexes Results in Major Histocompatibility Complex Class I Antigen Presentation via Two Distinct Processing Pathways , 2000, The Journal of experimental medicine.